title: A randomized phase II trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer.
authors.forename: M
authors.initials: M
authors.lastname: Colleoni
authors.forename: P
authors.initials: P
authors.lastname: Manente
authors.forename: J
authors.initials: J
authors.lastname: Stocker
authors.forename: H
authors.initials: H
authors.lastname: Amor
authors.forename: S
authors.initials: S
authors.lastname: Lamon
authors.forename: P
authors.initials: P
authors.lastname: Nelli
authors.forename: G
authors.initials: G
authors.lastname: Vicario
authors.forename: G
authors.initials: G
authors.lastname: Sgarbossa
authors.forename: C
authors.initials: C
authors.lastname: Graiff
mesh_terms: D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D016685:Mitomycin; D014747:Vinblastine; D000077235:Vinorelbine